论文部分内容阅读
目的:观察短期胰岛素强化治疗初诊2型糖尿病患者的血糖控制的临床疗效。方法:选择在2013年3月份到8月份期间我院门诊进行治疗的40例初诊为2型糖尿病患者,空腹血糖(FPG)>13.0mmol/L,并且没有并发症,采用自身前后对照,给予胰岛素强化治疗2周,比较治疗前后空腹血糖(FPG)、餐后2小时血糖(2hPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)等指标。结果:作为研究对象的患者经治疗以后空腹血糖、餐后2小时血糖同治疗前相比较存在很明显的差异(P<0.01)。结论:短期胰岛素强化治疗初诊2型糖尿病,不仅可以非常有效的控制空腹和餐后的血糖,并且糖化血红蛋白水平较前下降,空腹胰岛素水平较前升高,有着非常重要的临床应用价值。
Objective: To observe the clinical efficacy of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Methods: Forty newly diagnosed type 2 diabetic patients treated in our hospital from March to August 2013 were selected. Their fasting plasma glucose (FPG)> 13.0mmol / L was selected and compared with their own control before and after treatment with insulin Intensive treatment for 2 weeks, before and after treatment fasting blood glucose (FPG), 2 hours postprandial blood glucose (2hPG), HbA1c, fasting insulin (FINS) and other indicators. Results: The fasting blood glucose (FBG) after treatment was significantly different between the two groups (P <0.01). CONCLUSION: Short-term intensive insulin treatment of newly diagnosed type 2 diabetes mellitus can not only control fasting and postprandial blood glucose very effectively, but also reduce the level of HbA1c and increase the level of fasting insulin, which has a very important clinical value.